Phase 4
Completed N=218
Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3
Source: ClinicalTrials.gov NCT00719732 ↗Enrolled (actual)
218
Serious AEs
0.5%
Results posted
Mar 2010
Primary outcomePrimary: Uncorrected Visual Acuity (UCVA) — 0.05; -0.07; 0.15; 0.20 logMAR
Summary
A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Uncorrected Visual Acuity (UCVA) |
0.05; -0.07; 0.15; 0.20; -0.01 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosed with cataracts
Exclusion Criteria
- Pre-existing conditions that could skew the results or are contraindications for the ReSTOR intraocular lens;
- <1 diopter astigmatism by keratometry readings.
Data sourced from ClinicalTrials.gov (NCT00719732). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.